Home > Healthcare > Medical Devices > Diagnostic Devices > ovulation testing kits market
Get a free sample of Ovulation Testing Kits Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ovulation Testing Kits Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Ovulation Testing Kits Market size was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032. Ovulation testing kits are diagnostic tools that help women, determine the most fertile days of their menstrual cycle by detecting the surge in hormones, which precedes ovulation.
The WHO estimates that polycystic ovary syndrome (PCOS) affects an estimated 8-13% of reproductive-aged women, and up to 70% of affected women remain undiagnosed. Therefore, the increasing prevalence of PCOS and hormonal disorders underscores the growing demand for accurate ovulation testing kits, enabling affected women to track their cycles and enhance their conception prospects.
Furthermore, with the burgeoning awareness surrounding in-vitro fertilization (IVF) services, an increasing number of couples are actively pursuing avenues to enhance their fertility. Thus, ovulation testing kits play a pivotal role in this journey, empowering individuals to meticulously time their fertility treatments and, in turn, heighten their prospects of achieving successful IVF.
U.S. ovulation testing kits market accounted for USD 672 million in 2022 and is predicted to witness substantial growth through 2032 primarily due to the region
Swiss Precision Diagnostics GmbH (Clearblue), ClinicalGuard, Wondfo, AccuMed, PREGMATE, iProven, and Wellify (Piramal group), Femometer, Proov, Easy@Home Fertility, Ro, Fairhaven Health, and Prega News (Mankind pharma).
The pharmacies and drugstores segment accounted for over 41% market share in 2022 and will grow through 2032 as these stores offer easy accessibility, provide professional guidance, and a variety of product options.
The global ovulation testing kits indystry was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032.